Literature DB >> 16830961

Primary spindle cell lesions of the thyroid gland; an overview.

Giampaolo Papi1, Stefania Corrado, Virginia A LiVolsi.   

Abstract

Spindle cell lesions of the thyroid gland (T-SCL) are not encountered routinely in clinical practice or in the context of thyroid pathology. They commonly are classified as primary or secondary to metastatic disease. Primary T-SCL can be derivedfromfollicular, C-cell (parafollicular), or mesenchymal components and may be the result of reactive or neoplastic processes, including post-fine-needle aspiration spindle cell nodules, Riedel thyroiditis, solitary fibrous tumor, leiomyoma, peripheral nerve sheath tumor, hyalinizing trabecular tumor, spindle epithelial tumor with thymus-like differentiation, follicular dendritic cell tumor, medullary carcinoma, papillary carcinoma, anaplastic carcinoma, sarcoma, squamous cell carcinoma, and carcinoma showing thymus-like differentiation. Because T-SCL may represent the expression of benign and highly malignant neoplasms, distinction among these processes is crucial because it dictates therapy and defines prognosis. The present article reviews the clinical, imaging, pathologic, and immunohistochemical characteristics of primary T-SCL.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16830961     DOI: 10.1309/4DQW6RQX3C6KRX1J

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  15 in total

Review 1.  Follicular thyroid adenoma dominated by spindle cells: report of two unusual cases and literature review.

Authors:  Abbas Agaimy; Thomas Hahn; Josef Schroeder; Afaf Elhag
Journal:  Int J Clin Exp Pathol       Date:  2012-02-12

2.  Not All Post-FNA Spindle Cell Proliferations in the Thyroid Are of Myofibroblastic Origin: Follicular Adenoma with Spindle Cell Metaplasia.

Authors:  Gülçin Yegen; Melek Büyük; İsmail Cem Solmaz; Semen Önder; Şule Öztürk; Özgür Mete
Journal:  Endocr Pathol       Date:  2015-12       Impact factor: 3.943

3.  Solitary fibrous tumor of the thyroid gland.

Authors:  Yusuke Mizuuchi; Hidetaka Yamamoto; Katsuya Nakamura; Kengo Shirahane; Masae Souzaki; Masao Tanaka; Yoshinao Oda
Journal:  Med Mol Morphol       Date:  2013-09-08       Impact factor: 2.309

4.  Spindle cell sarcoma of thyroid: a case report.

Authors:  A K Abdul Siyad; Praveen Gopi; N P Jayan; Joy Augustine
Journal:  Indian J Surg Oncol       Date:  2014-10-08

Review 5.  Spindle epithelial tumor with thymus-like differentiation (SETTLE): clinical-pathological features, differential pathological diagnosis and therapy.

Authors:  Serena Ippolito; Claudio Bellevicine; Debora Arpaia; Carmela Peirce; Giuseppe Ciancia; Elena Vigliar; Giancarlo Troncone; Bernadette Biondi
Journal:  Endocrine       Date:  2015-08-20       Impact factor: 3.633

6.  Leiomyosarcoma: a rare tumor of the thyroid.

Authors:  Jantima Tanboon; Phawin Keskool
Journal:  Endocr Pathol       Date:  2013-09       Impact factor: 3.943

7.  A small subgroup of Hashimoto's thyroiditis is associated with IgG4-related disease.

Authors:  Friedrich Jokisch; Irene Kleinlein; Bernhard Haller; Tanja Seehaus; Heinrich Fuerst; Marcus Kremer
Journal:  Virchows Arch       Date:  2015-12-15       Impact factor: 4.064

8.  Malignant peripheral nerve sheath tumour of thyroid: a diagnostic dilemma.

Authors:  Muhammad Hassan Danish; Muhammad Wasif; Nasir Ud Din; Muhammad Sohail Awan
Journal:  BMJ Case Rep       Date:  2020-04-22

9.  Solitary fibrous tumor of the intrathoracic goiter.

Authors:  Mohammad Vaziri; Saadat Molanaei; Zeinab Tamannaei
Journal:  Med J Islam Repub Iran       Date:  2014-07-07

10.  Papillary thyroid carcinoma with prominent myofibroblastic stromal component: clinicopathologic, immunohistochemical and next-generation sequencing study of seven cases.

Authors:  David Suster; Michael Michal; Michiya Nishino; Simonetta Piana; Massimo Bongiovanni; Olga Blatnik; Veronika Hájková; Nikola Ptáková; Michal Michal; Saul Suster
Journal:  Mod Pathol       Date:  2020-04-14       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.